NHS Norwich and Norfolk spin-out Ablatus Therapeutics is at the forefront of radiofrequency ablation, an innovation which can destroy solid tumours without the need for invasive surgery. We speak to the team to find out how its new ablation technique could disrupt the tumour treatment space.

Also in this issue, we take a look at some of the core characteristics that have made Germany’s medical device market so successful, review technologies that are helping to challenge misinformation and improve adult vaccination rates, and examine how the US’s trade war with China is undermining the medical device industry.

Plus, we find out about a new light-emitting implant device that is poised to take photodynamic therapy to the next level, uncover the budding promise of 3D biopsies with researchers from RMIT University in Australia, and profile different research strands that are working to predict and prevent cardiac disease.

Finally, we check in with CMR’s Versius robotic surgery system to see how the company has developed over the past 18 months, and, as always, we get the latest insight and market trends from GlobalData’s team of experts and analysts.

Eloise McLennan, editor